What is William Blair's Forecast for PBH FY2025 Earnings?

Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) - Investment analysts at William Blair increased their FY2025 EPS estimates for Prestige Consumer Healthcare in a research note issued to investors on Thursday, February 6th. William Blair analyst J. Andersen now expects that the company will post earnings per share of $4.50 for the year, up from their previous estimate of $4.42. The consensus estimate for Prestige Consumer Healthcare's current full-year earnings is $4.50 per share. William Blair also issued estimates for Prestige Consumer Healthcare's Q4 2025 earnings at $1.30 EPS and FY2026 earnings at $4.75 EPS.

PBH has been the topic of several other research reports. Canaccord Genuity Group upped their target price on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. Sidoti cut Prestige Consumer Healthcare from a "buy" rating to a "neutral" rating and set a $90.00 price objective on the stock. in a research report on Monday, December 9th. Oppenheimer lifted their target price on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a report on Thursday. StockNews.com raised Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Friday, January 24th. Finally, Raymond James upgraded Prestige Consumer Healthcare to a "moderate buy" rating in a report on Thursday, December 19th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, Prestige Consumer Healthcare presently has a consensus rating of "Moderate Buy" and a consensus target price of $92.60.

Prestige Consumer Healthcare Stock Up 1.7 %

Prestige Consumer Healthcare stock traded up $1.47 during mid-day trading on Monday, reaching $85.68. The stock had a trading volume of 343,329 shares, compared to its average volume of 320,656. The company has a market capitalization of $4.23 billion, a price-to-earnings ratio of 20.07, a PEG ratio of 2.43 and a beta of 0.50. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.10. Prestige Consumer Healthcare has a one year low of $62.35 and a one year high of $88.36. The company has a 50-day moving average price of $79.27 and a two-hundred day moving average price of $75.80.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its earnings results on Thursday, February 6th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%.

Insider Activity at Prestige Consumer Healthcare

In other news, CEO Ronald M. Lombardi sold 10,875 shares of the firm's stock in a transaction dated Tuesday, November 19th. The stock was sold at an average price of $82.60, for a total value of $898,275.00. Following the transaction, the chief executive officer now owns 320,952 shares of the company's stock, valued at $26,510,635.20. This trade represents a 3.28 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.60% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Prestige Consumer Healthcare

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Martingale Asset Management L P increased its stake in shares of Prestige Consumer Healthcare by 0.4% in the third quarter. Martingale Asset Management L P now owns 36,971 shares of the company's stock worth $2,666,000 after purchasing an additional 140 shares in the last quarter. Horizon Kinetics Asset Management LLC grew its position in shares of Prestige Consumer Healthcare by 4.8% during the third quarter. Horizon Kinetics Asset Management LLC now owns 3,247 shares of the company's stock worth $234,000 after purchasing an additional 150 shares in the last quarter. Franklin Resources Inc. raised its stake in Prestige Consumer Healthcare by 0.7% during the 4th quarter. Franklin Resources Inc. now owns 21,735 shares of the company's stock valued at $1,697,000 after purchasing an additional 150 shares during the period. CIBC Private Wealth Group LLC lifted its holdings in Prestige Consumer Healthcare by 48.9% in the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock worth $34,000 after purchasing an additional 152 shares in the last quarter. Finally, OLD National Bancorp IN grew its holdings in Prestige Consumer Healthcare by 4.4% during the 3rd quarter. OLD National Bancorp IN now owns 3,974 shares of the company's stock valued at $287,000 after buying an additional 168 shares in the last quarter. Institutional investors own 99.95% of the company's stock.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.